No connection

Search Results

L vs NMR

L
Loews Corporation
NEUTRAL
Price
$112.37
Market Cap
$23.12B
Sector
Financial Services
AI Confidence
75%
NMR
Nomura Holdings, Inc.
NEUTRAL
Price
$8.06
Market Cap
$23.27B
Sector
Financial Services
AI Confidence
85%

Valuation

P/E Ratio
L
14.1
NMR
10.75
Forward P/E
L
38.75
NMR
14.39
P/B Ratio
L
1.24
NMR
1.03
P/S Ratio
L
1.25
NMR
0.01
EV/EBITDA
L
8.23
NMR
--

Profitability

Gross Margin
L
36.5%
NMR
78.31%
Operating Margin
L
13.08%
NMR
18.66%
Profit Margin
L
9.03%
NMR
16.71%
ROE
L
9.43%
NMR
10.07%
ROA
L
1.97%
NMR
0.63%

Growth

Revenue Growth
L
4.1%
NMR
27.5%
Earnings Growth
L
126.0%
NMR
4.5%

Financial Health

Debt/Equity
L
0.5
NMR
9.17
Current Ratio
L
0.51
NMR
1.57
Quick Ratio
L
0.32
NMR
1.56

Dividends

Dividend Yield
L
0.22%
NMR
5.11%
Payout Ratio
L
3.14%
NMR
21.73%

AI Verdict

L NEUTRAL

Loews Corporation presents a complex profile with a stable Piotroski F-Score of 4/9 and significant valuation upside based on a Graham Number of $127.54 and an Intrinsic Value of $235.11. While the stock is fundamentally undervalued and has shown strong 1-year price performance (+31.1%), these positives are countered by a bearish insider sentiment and a concerning jump in Forward P/E (38.75 vs 14.10), suggesting an expected earnings contraction. The company's health is stable but liquidity is tight, as evidenced by a low current ratio of 0.51.

Strengths
Significant undervaluation relative to Graham Number ($127.54) and Intrinsic Value ($235.11)
Strong 1-year price appreciation of 31.1%
Conservative Debt/Equity ratio of 0.50
Risks
Bearish insider activity with $22.77M in net sales and zero buys
Poor short-term liquidity indicated by a Current Ratio of 0.51 and Quick Ratio of 0.32
Significant Forward P/E expansion (38.75) suggesting a projected decline in future earnings
NMR NEUTRAL

Nomura Holdings presents a stark contrast between attractive valuation and poor operational health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($11.50) and Intrinsic Value ($10.31), the fundamental health metrics are concerning. Strong revenue growth and a healthy dividend yield are offset by extreme leverage (Debt/Equity of 9.17) and a consistent track record of missing earnings estimates. The current price of $8.06 suggests a value play, but the lack of operational momentum warrants a neutral stance.

Strengths
Trading at a significant discount to Graham Number ($11.50) and Intrinsic Value ($10.31)
Strong dividend yield of 5.11% with a sustainable payout ratio of 21.73%
Robust year-over-year revenue growth of 27.50%
Risks
Critically low Piotroski F-Score (2/9) indicating deteriorating financial health
Extreme leverage with a Debt/Equity ratio of 9.17
Poor earnings reliability, beating estimates in only 1 of the last 4 quarters

Compare Another Pair

L vs NMR: Head-to-Head Comparison

This page compares Loews Corporation (L) and Nomura Holdings, Inc. (NMR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile